Anterix (ATEX) R&D/CAPEX US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 60.8% | 30.6% | 13.1% | 16.4% | 32.9% | 39.3% | |||
Changes by years, y/y, % | -78pp | -30pp | -18pp | +3pp | +16pp | -25.0% |
Anterix. R&D/CAPEX, %
Anterix. R&D/CAPEX, changes, pp
Anterix (ATEX) R&D/CAPEX US GAAP (quarter values) |
||||||||
2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
R&D/CAPEX, % | 22.5% | 25.9% | 99.2% | 32.4% | 32.9% | 39.3% | ||
Changes by years, y/y, % | +5pp | +15pp | +77pp | +12pp | +10pp | |||
Changes by quarters, q/q, % | +2pp | +3pp | +73pp | -67pp | +0pp |